CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antognini, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antognini, J. F.

Canadian Journal of Anesthesia, Vol 43, 310-314, Copyright © 1996 by Canadian Anesthesiologists' Society


ARTICLES

Movement associated with high cerebral concentrations of isoflurane: no evidence of seizure activity

JF Antognini
Department of Anesthesiology, University of California, Davis 95616, USA. jfantognini@ucdavis.edu

PURPOSE: This study examined the effect of high cerebral concentrations of isoflurane on the electroencephalogram (EEG) and motor activity while using an experimental preparation in which isoflurane can be selectively delivered to the in situ goat brain. In a previous study we found that isoflurane (> 6%), when selectively delivered to the brain, was associated with spontaneous movement. METHODS: In each of six goats, the cerebral circulation was isolated and cannulae inserted into a carotid artery and the jugular veins to permit selective delivery of isoflurane using a bubble oxygenator-roller pump system. The EEG was measured while isoflurane (1.3%, 3% and 10-12%) was delivered to the brain; isoflurane concentration in the torso during these periods was 1.3%, 0.3% and 0.3% respectively. RESULTS: The EEG was active at isoflurane 1.3% but was isoelectric with spike activity at 3% and 10-12%; EEG power decreased from 32,249 +/- 15,241 microV2 (mean +/- sd) during the control period (isoflurane = 1.3%) to 1761 +/- 2435 microV2 when cranial isoflurane = 3%, and 3346 +/- 4780 microV2 when cranial isoflurane = 10-12% (P < 0.05). When cranial isoflurane concentration was 10-12%, with the torso isoflurane concentration at 0.3%, spontaneous motor activity occurred, including stiffening, extremity and jaw movement and blinking. The EEG returned to normal when isoflurane concentration was decreased to 1.3%. CONCLUSION: The presence of spontaneous movement with concomitant high cranial concentrations of isoflurane and isoelectric EEG is unexplained, but is consistent with a facilitatory effect of isoflurane on motor activity, presumably at a subcortical level.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the Canadian Anesthesiologists' Society.